SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-159809
Filing Date
2021-05-13
Accepted
2021-05-13 07:06:24
Documents
56
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d51517d10q.htm 10-Q 951340
2 EX-10.12 d51517dex1012.htm EX-10.12 22471
3 EX-10.13 d51517dex1013.htm EX-10.13 256707
4 EX-31.1 d51517dex311.htm EX-31.1 7306
5 EX-31.2 d51517dex312.htm EX-31.2 7256
6 EX-32.1 d51517dex321.htm EX-32.1 3637
7 EX-32.2 d51517dex322.htm EX-32.2 3673
  Complete submission text file 0001193125-21-159809.txt   4473567

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snss-20210331.xml EX-101.INS 625332
9 XBRL TAXONOMY EXTENSION SCHEMA snss-20210331.xsd EX-101.SCH 45405
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20210331_cal.xml EX-101.CAL 33324
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20210331_def.xml EX-101.DEF 221491
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20210331_lab.xml EX-101.LAB 396526
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20210331_pre.xml EX-101.PRE 309779
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 21917157
SIC: 2834 Pharmaceutical Preparations